Liposomal Doxorubicin-containing Front-line Treatment in Elderly Patients With HL (HL-MVD)

NCT06235047 · clinicaltrials.gov ↗
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Federico II University